FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
National Research Corporation Stock AnalysisComprehensive stock analysis for National Research Corporation (NRC) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisNRC
NRC
National Research Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
NRC
Home🔹Stocks🔹National Research Corporation

National Research Corporation

🇺🇸NRC•NASDAQ

National Research Corporation

🇺🇸NRC•NASDAQ
Market cap
$475.98M
Sentiment

Your view on NRC

Mkt Cap
$475.98M
Sentiment
Your view
NRC
National Research Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
NRC
Company Overview

Overview

What the company does, where it operates, and who runs it.

About National Research Corporation

Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Trent Green
Headquarters
1245 Q Street, Lincoln, NE, US
Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Trent Green
Headquarters
1245 Q Street, Lincoln, NE, US
Description

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada.

Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.

In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools.

Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions.

Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership.

The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for National Research Corporation, and the rating behind it. NRC last traded at $21.12, 80.1× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for National Research Corporation. Starting points for National Research Corporation: P/E 80.1, EPS $0.27, beta 0.38 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for National Research Corporation. National Research Corporation paid $0.60 per share over the last year — a 2.8% yield at the current $21.12 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for National Research Corporation. Trailing twelve-month EPS for National Research Corporation stands at $0.27. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for National Research Corporation. National Research Corporation has reported as a listed company since 2013. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

National Research Corporation valued side by side against its closest peers. National Research Corporation is measured against Medical - Healthcare Information Services peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold National Research Corporation, and how their positions are changing. At a $476.0M market value, institutional positions materially move National Research Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by National Research Corporation executives and directors. Shares of National Research Corporation have traded between $9.76 and $20.11 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming National Research Corporation. National Research Corporation is a $476.0M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming National Research Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for National Research Corporation. Coverage tracks National Research Corporation within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • DH — Definitive Healthcare Corp.
  • HCAT — Health Catalyst, Inc.
  • NNOX — Nano-X Imaging Ltd.
  • PBYI — Puma Biotechnology, Inc.
  • QTRX — Quanterix Corporation
  • SNWV — SANUWAVE Health, Inc.
  • SOPH — SOPHiA GENETICS S.A.
  • SPOK — Spok Holdings, Inc.

More Medical - Healthcare Information Services companies

  • ICR.AX — Intelicare Holdings Limited
  • IGRW — Interactive Health Network
  • LFCOF — Lift & Co. Corp.
  • LFMD — LifeMD, Inc.
  • LFMDP — LifeMD, Inc.
  • LVCE — LiveCare, Inc.
  • LYNX.CN — Lynx Global Digital Finance Corporation
  • M7T.AX — Mach7 Technologies Limited
  • MDBIF — TrivarX Limited
  • MDNWF — Mednow Inc.
  • MDRX — Veradigm Inc.
  • MDXL — MediXall Group, Inc.

ETFs holding National Research Corporation

  • DEEP — Acquirers Small and Micro Deep Value ETF (1.12%)
  • RFDA — RiverFront Dynamic US Dividend Advantage ETF (1.11%)
  • ROSC — Hartford Multifactor Small Cap ETF (0.38%)
  • AIMS — Acuitas Small Cap Active ETF (0.27%)
  • DGRS — WisdomTree U.S. SmallCap Quality Dividend Growth Fund (0.27%)
  • SMLV — State Street SPDR US Small Cap Low Volatility Index ETF (0.13%)
  • DES — WisdomTree U.S. SmallCap Dividend Fund (0.13%)
  • FSMD — FIDELITY SMALL-MID MULTIFACTOR ETF (0.09%)

News

Latest Market News